Pancreatic Cancer Research

ResearcherKobe Medical CenterActive in the last 2 years

Hisateru Yasui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5563-5802; OpenAlex author ID A5068132612. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase I… Co-author DOI 10.1016/j.ejca.2026.117034↗
  2. FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study). Co-author DOI 10.21873/cdp.10083↗
  3. Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial). Co-author DOI 10.1007/s00280-020-04174-1↗
  4. Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report. Last author DOI 10.1159/000481398↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hironobu Minami · 2 shared papers, 2021–2026 · strength 0.36
  2. Hirochika Toyama · 2 shared papers, 2021–2026 · strength 0.36
  3. Yukimasa Hatachi · 2 shared papers, 2017–2022 · strength 0.26
  4. Yoshiaki Nagatani · 1 shared paper, 2026 · strength 0.24
  5. Akihito Tsuji · 1 shared paper, 2022 · strength 0.17
  6. Satoshi Sai · 1 shared paper, 2021 · strength 0.11
  7. Yuzo Kodama · 1 shared paper, 2021 · strength 0.11
  8. Takatsugu Ogata · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.